OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Natalay Kouprina

Natalay Kouprina

Staff Scientist
National Cancer Institute
USA
Tel: 301-496-7941
Fax: 301-480-2772

Biography

Natalay Kouprina received her M.Sc. in physical chemistry from the St. Petersburg State University, Russia, and her Ph.D. and Dr.Sc. in cell biology from the Institute of Cytology, Russian Academy of Sciences. While in Russia, she worked on the identification of genes that control the replication and segregation of chromosomes in budding yeast. In 1991 she moved to the United States and focused her interests on genomics. At present she is a staff scientist at the National Cancer Institute, USA. Her current interest is to combine a transformation-associated recombination (TAR) cloning technology that allows selective isolation of a gene of interest up to 300 kb in size from complex genomes, including humans, with the human artificial chromosome or HAC-based gene delivery vector to develop a novel system for the delivery and expression of full-length mammalian genes. Such a novel approach has a potential for gene functional studies and gene therapy. She has 83 publications in many leading journals.

Research

Combining a transformation-associated recombination (TAR) cloning technology that allows selective isolation of a gene of interest up to 300 kb in size from complex genomes, including humans, with the human artificial chromosome or HAC-based gene delivery vector to develop a novel system for the delivery and expression of full-length mammalian genes.